Posted on 12 月 2, 202412/2/24
Patient Centric 3.0: Why a Direct-to-Patient Model Is a Game Changer
Posted on 11 月 27, 202411/27/24
From Challenges to Solutions: Breaking Barriers to Revolutionize Patient Services
Posted on 10 月 2, 202410/2/24
AI, Digital Therapeutics Transformation & Cross-Industry Collaboration – What’s On Tap at Frontiers Health
Posted on 9 月 5, 20249/5/24
The Promise of a Direct-to-Patient Model – Breaking Down What’s Really Needed for Better Patient Access
Posted on 8 月 13, 20248/13/24
IDN Trends, Insights and Strategies Every Manufacturer Should Know
Posted on 7 月 8, 20247/8/24
Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know
Posted on 7 月 3, 20247/3/24
Transforming the Future of Pharma Commercialization Through Medical Affairs
Posted on 6 月 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on 6 月 24, 20246/24/24
Market Access and the Inflation Reduction Act
Posted on 6 月 21, 20246/21/24